Steven DuBois

USA

Steven DuBois

USA

Biography

Dr. DuBois completed medical school and pediatric training at the University of California, San Francisco (UCSF). He completed pediatric oncology training at Dana-Farber / Boston Children’s Hospital and obtained a Master of Science in Epidemiology from the Harvard School of Public Health. He is currently an Associate Professor of Pediatrics at Harvard Medical School. He is the Director of Experimental Therapeutics at Dana-Farber / Boston Children’s Cancer and Blood Disorders Center where he leads a program designed to bring new targeted therapies to children with cancer.

Dr. DuBois leads an active clinical and translational research program focused on children with advanced neuroblastoma. He conducts clinical trials of novel targeted agents relevant to this disease, including national phase 1, 2, and 3 clinical trials. He also studies new biomarkers that improve our understanding of the biology of neuroblastoma and of the pharmacodynamic effects of targeted therapies.

Dr. DuBois has served on a number of national committees, including the Children’s Oncology Group (COG) Neuroblastoma Steering Committee, COG Bone Tumor Committee, COG Developmental Therapeutics Executive Committee, the American Society of Clinical Oncology (ASCO) Scientific Program Committee, and the US FDA Pediatric Oncology Drugs Advisory Committee (ODAC).